CESTMOI_1170x120_11-14-18

Pfizer Inc.

GSK, Pfizer create joint venture

WARREN, N.J. — Pfizer Inc. and GlaxoSmithKline PLC (GSK) have entered into an agreement that will create a premier global consumer health care company with robust iconic brands. The boards of directors of both companies have unanimously approved the transaction under which Pfizer will contribute its consumer health care business to GSK’s existing consumer health

Pfizer to reorganize, creating three business units

Pfizer to reorganize, creating three business units

NEW YORK — Pfizer Inc. announced it will organize the company into three businesses: a science-based Innovative Medicines business which will now include biosimilars and a new hospital business unit for anti-infectives and sterile injectables; an off-patent branded and generic Established Medicines business operating with substantial autonomy within Pfizer; and a Consumer Healthcare business. These

Pfizer mulls possible sale of consumer health unit

Pfizer mulls possible sale of consumer health unit

NEW YORK — Pfizer Inc. is assessing strategic options for its Pfizer Consumer Healthcare subsidiary, including a potential sale. The pharmaceutical giant said this week that it’s considering “a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction.” However, the company noted that it may decided

Pfizer, Allergan abandon $160 billion merger plan

Pfizer, Allergan abandon $160 billion merger plan

NEW YORK — Pfizer Inc. said Wednesday that its merger agreement with Allergan PLC has been terminated by mutual agreement, a decision driven by the Treasury Department’s announcement of new rules intended to undercut this type of tax inversion deal. The move is a major victory for the Obama administration in its campaign against inversions,